Market Highlights

Market Research Future (MRFR) studied the global ophthalmic drugs market 2021 for the review period till 2025. As per MRFR assessment, the global market of ophthalmic drugs is anticipated to register 5.1% CAGR over the forecast term. By 2025, the ophthalmic drugs market value can touch USD 29.46 Bn.

Drivers and Restrains Impacting Ophthalmic Drugs Market 

Ophthalmic drugs are used in the treatment of eye infection and other types of eye conditions. The growing prevalence of ophthalmic diseases, such as; age-related macular degeneration (AMD), diabetic retinopathy, diabetic macular edema (DME), myopic choroidal neovascularization, and retinal vein occlusion (RVO), are potential threats to an individual’s sight.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5753 

The expansion of the global ophthalmic drugs market can be influenced by surge in investments in the development of novel drugs and escalation of funding for research on the formulation of ophthalmic drugs. In addition, the surging incidences and ongoing prevalence of eye-related disorders are other causes are expected to fuel the ophthalmic drugs market growth. The growing relationship among key companies can influence the ophthalmic drugs market and churn-up high revenue. For instance, Johnson & Johnson Surgical Vision, Inc. entered into a research collaboration with the Singapore Eye Research Institute (SERI) and National Eye Centre (SNEC) to tackle myopia. In addition, the Essilor signed a new research agreement Laas-CNRS laboratory for five years. Other major companies operating in the ophthalmic drugs market are involved in product launch, strategic acquisitions, collaborations to improve their global position.

Segmental Analysis

The Global Ophthalmic Drugs Market has been segmented based on  product type, dosage form, indication, drug class, and region.

The global ophthalmic drugs market, on the basis of dosage form, has been segmented into eye ointments, gels, eye solutions, capsules & tablets, eye drops, others.

The global ophthalmic drugs market, on the basis of drug class, has been divided into anti-glaucoma, anti-inflammatory, antibiotics, and others.

The global ophthalmic drugs market, based on product type, has been divided into prescription drug and over the counter (OTC) drug.

The global ophthalmic drugs market, on the basis of  indication, has been segmented into glaucoma, allergy, dry eye, and others.

Regional Overview

Due to the increasing number of geriatric individuals and the involvement of major existing players in the region, the ophthalmic drugs industry in the Americas is expected to dominate the eye drugs market. In addition, the emergence of patient population , increased incidence of eye diseases, well-developed infrastructure , high healthcare spending are also projected to lead to the increasing development of the regional sector.

The European demand for ophthalmic drugs has seen substantial development which can be due to the growing incidence of eye diseases. Owing to the growing pool of eye-related patient population and the expansion of healthcare services anticipated to fuel demand growth, the Asia-Pacific ophthalmic drugs market is estimated to have a steady growth rate during the forecast period.

The Middle East & Africa ophthalmic drugs industry is predicted to account for the least share of the global demand owing to poor disposable per capita income in the area.

Competitive Dashboard

The major Players operating in the Global Ophthalmic Drugs Market are  Allergan Plc, F. Hoffmann-La Roche AG, Novartis AG, Bausch Health Companies Inc., Pfizer Inc., Bayer AG, Merck & Co., Inc., Aerie Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753 

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.j

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com